Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016

The future of haematopathology

Prof Alberto Zamo - University of Verona, Verona, Italy
The future of haematopathology ( Prof Alberto Zamo - University of Verona, Verona, Italy )
27 Apr 2016

Frontline therapy in young patients with myeloma

Prof Philippe Moreau - University of Nantes, Nantes, France
Frontline therapy in young patients with myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
27 Apr 2016

Cell of origin role in cancer stem cell and GBM phenotype

Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA
Cell of origin role in cancer stem cell and GBM phenotype ( Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA )
27 Apr 2016

New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations

Dr Jayesh Desai - Royal Melbourne Hospital, Melbourne, Australia
New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations ( Dr Jayesh Desai - Royal Melbourne Hospital, Melbourne, Australia )
27 Apr 2016

MINDACT breast cancer clinical trial: First results and impact on future trial design

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
MINDACT breast cancer clinical trial: First results and impact on future trial design ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
27 Apr 2016

BSH 2016: Expert discussion on front line care in CLL

Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on front line care in CLL ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016

BSH 2016: Expert discussion on idelalisib

Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on idelalisib ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016

Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance

Dr Marianne Ratcliffe - AstraZeneca, UK
Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance ( Dr Marianne Ratcliffe - AstraZeneca, UK )
26 Apr 2016

Next-generation sequencing in the lymphoid malignancies

Dr Aaron Logan - UCSF, San Fransisco, USA
Next-generation sequencing in the lymphoid malignancies ( Dr Aaron Logan - UCSF, San Fransisco, USA )
26 Apr 2016

Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy

Dr Nicholas McGranahan - Crick Institute, London, UK
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy ( Dr Nicholas McGranahan - Crick Institute, London, UK )
26 Apr 2016

Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy

Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA
Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy ( Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA )
26 Apr 2016